Quince Therapeutics Provides Business Update and Reports Fiscal Year 2024 Financial Results

Quince Therapeutics Provides Business Update and Reports Fiscal Year 2024 Financial Results
Phase 3 clean clinical trial is exceeding 50 % entry with new study site activities, which is expected to be ...
Read more